These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18179388)

  • 21. Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona, USA.
    Weber IB; Lindsey NP; Bunko-Patterson AM; Briggs G; Wadleigh TJ; Sylvester TL; Levy C; Komatsu KK; Lehman JA; Fischer M; Staples JE
    Epidemiol Infect; 2012 Sep; 140(9):1632-6. PubMed ID: 22123531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. West Nile virus activity--United States, July 28-August 3, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Aug; 53(30):686-7. PubMed ID: 15295314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis.
    Cahill ME; Conley S; DeWan AT; Montgomery RR
    BMC Infect Dis; 2018 Jun; 18(1):282. PubMed ID: 29929468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. West Nile virus activity--United States, August 4-10, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Aug; 53(31):719-20. PubMed ID: 15306758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virus and host determinants of West Nile virus pathogenesis.
    Diamond MS
    PLoS Pathog; 2009 Jun; 5(6):e1000452. PubMed ID: 19557199
    [No Abstract]   [Full Text] [Related]  

  • 26. West Nile virus activity--United States, August 25-31, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(34):795-6. PubMed ID: 15343148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. West Nile virus activity United States, July 7-13, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):615. PubMed ID: 15254454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. West Nile Virus Activity--United States, October 13-19, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(41):971-2. PubMed ID: 15499683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-year sequelae in patients with West Nile Virus encephalitis and meningitis in Louisiana.
    Ou AC; Ratard RC
    J La State Med Soc; 2005; 157(1):42-6. PubMed ID: 15887668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective behavior and West Nile virus risk.
    Loeb M; Elliott SJ; Gibson B; Fearon M; Nosal R; Drebot M; D'Cuhna C; Harrington D; Smith S; George P; Eyles J
    Emerg Infect Dis; 2005 Sep; 11(9):1433-6. PubMed ID: 16229774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. West Nile virus activity--United States, September 8-14, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(36):850-1. PubMed ID: 15371969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. West Nile virus: should pediatricians care?
    Smith JC; Mailman T; MacDonald NE
    J Infect; 2014 Nov; 69 Suppl 1():S70-6. PubMed ID: 25138381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003.
    Lindsey NP; Sejvar JJ; Bode AV; Pape WJ; Campbell GL
    Vector Borne Zoonotic Dis; 2012 Mar; 12(3):230-5. PubMed ID: 22022816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996.
    Han LL; Popovici F; Alexander JP; Laurentia V; Tengelsen LA; Cernescu C; Gary HE; Ion-Nedelcu N; Campbell GL; Tsai TF
    J Infect Dis; 1999 Jan; 179(1):230-3. PubMed ID: 9841844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Versus Nonprimary West Nile Virus Infection: A Cohort Study.
    Rahav G; Hagin M; Maor Y; Yahalom G; Hindiyeh M; Mendelson E; Bin H
    J Infect Dis; 2016 Mar; 213(5):755-61. PubMed ID: 26508125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [West Nile virus. II. Immunopathophysiology in humans].
    Lanteri MC; Diamond MS; Norris PJ; Busch MP
    Med Sci (Paris); 2011 Apr; 27(4):382-6. PubMed ID: 21524402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States.
    Hayes EB; Gubler DJ
    Annu Rev Med; 2006; 57():181-94. PubMed ID: 16409144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. West Nile virus infection in kidney and pancreas transplant recipients in the Dallas-Fort Worth Metroplex during the 2012 Texas epidemic.
    Yango AF; Fischbach BV; Levy M; Chandrakantan A; Tan V; Spak C; Melton L; Rice K; Barri Y; Rajagopal A; Klintmalm G
    Transplantation; 2014 May; 97(9):953-7. PubMed ID: 24827765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood group A and D negativity are associated with symptomatic West Nile virus infection.
    Kaidarova Z; Bravo MD; Kamel HT; Custer BS; Busch MP; Lanteri MC
    Transfusion; 2016 Jul; 56(7):1699-706. PubMed ID: 27189860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic.
    Schweitzer BK; Kramer WL; Sambol AR; Meza JL; Hinrichs SH; Iwen PC
    Clin Vaccine Immunol; 2006 Mar; 13(3):314-8. PubMed ID: 16522771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.